---
figid: PMC5646121__13045_2017_533_Fig3_HTML
figtitle: Direct and indirect targeting of the B cell receptor signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5646121
filename: 13045_2017_533_Fig3_HTML.jpg
figlink: /pmc/articles/PMC5646121/figure/Fig3/
number: F3
caption: Direct and indirect targeting of the B cell receptor signaling pathway. Direct
  inhibition of BCR signaling is highlighted in red, potential additional and/or synergistic
  inhibition strategies with available drugs or drugs in advanced clinical development
  are shown in blue. Only one example per class of inhibitors is shown
papertitle: The role of B cell antigen receptors in mantle cell lymphoma.
reftext: Michael Fichtner, et al. J Hematol Oncol. 2017;10:164.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9646037
figid_alias: PMC5646121__F3
figtype: Figure
redirect_from: /figures/PMC5646121__F3
ndex: 5374ab1c-ded0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5646121__13045_2017_533_Fig3_HTML.html
  '@type': Dataset
  description: Direct and indirect targeting of the B cell receptor signaling pathway.
    Direct inhibition of BCR signaling is highlighted in red, potential additional
    and/or synergistic inhibition strategies with available drugs or drugs in advanced
    clinical development are shown in blue. Only one example per class of inhibitors
    is shown
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - CD19
  - CD79B
  - PHF11
  - PIK3AP1
  - SYK
  - NCK1
  - BTK
  - BLNK
  - AKT1
  - AKT2
  - AKT3
  - PLCG2
  - MTOR
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - NFKB1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - BAY-11-7082
  - Enzastaurin
  - Selumetinib
  - Fostamatinib
  - Ibrutinib
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
